- 48k views
Hemodynamic Instability: Management
Haemodynamic instability refers to a state where a person's circulatory system is unable to maintain adequate blood flow and perfusion to vital organs, often resulting in a critical medical condition. This instability can manifest as low blood pressure, rapid heart rate, altered mental status, and organ dysfunction. Causes can range from severe infections, bleeding, heart failure, or traumatic injuries. Prompt evaluation, diagnosis, and intervention are crucial to address the underlying cause, stabilize the patient's haemodynamics, and prevent further deterioration, often involving interventions like fluid resuscitation, medications, or surgical procedures.
About the Speaker
Dr. Munish Chauhan
Medical officer, Dept of Emergency, Civil Hospital District Shimla, Dept of Health and family welfare, Himachal Pradesh
Dr. Munish Chauhan is currently working as Senior Consultant in Critical care Medicine at Fortis Memorial Institute , Gurgaon. He worked as FACULTY AND CO- DIRECTOR : ELSO Certified Comprehensive Adult ECMO Specialist Simulator Course. He has his expertise in ECMO, Critical Care Ultrasound, Simulator based Trainings. He has several Research Publications (national and international) and author of several chapters in textbooks of Critical care medicine.
Upcoming Case Discussions
H. pylori Treatment with PYELRA®: Best Practices
PYLERA® is a medication used for the treatment of Helicobacter pylori (H. pylori) infection, a common cause of stomach ulcers and gastritis. It contains a combination of three active ingredients: bismuth subcitrate potassium, metronidazole, and tetracycline. This combination works synergistically to eradicate H. pylori bacteria and reduce associated symptoms. Treatment with PYLERA® typically involves taking multiple capsules four times a day for a specified duration, as prescribed by a healthcare provider. It is important to follow the treatment regimen as directed and to discuss potential side effects
Management of Pulmonary Fibrosis
Pulmonary fibrosis is diagnosed through a combination of medical history, imaging studies (like high-resolution CT scans), pulmonary function tests, and sometimes lung biopsies. Treatment often involves medications such as corticosteroids, immunosuppressants (like azathioprine or mycophenolate), and antifibrotic drugs (such as pirfenidone or nintedanib) to slow disease progression and manage symptoms.Supplemental oxygen therapy is commonly prescribed to relieve shortness of breath and improve oxygen levels in the blood. This program combines exercise training, education, and breathing techniques to improve overall physical condition and quality of life. Patients with pulmonary fibrosis should receive vaccinations against influenza and pneumococcal pneumonia to reduce the risk of respiratory infections. In severe cases, lung transplantation may be considered for eligible patients to improve survival and quality of life. Treatments like nutritional support, psychological counseling, and palliative care can provide comprehensive support and symptom management.
Alcoholic Hepatitis: Management Strategies
Management of alcoholic hepatitis involves a comprehensive approach aimed at halting disease progression, managing symptoms, and promoting liver recovery. The cornerstone of treatment involves complete alcohol cessation to prevent further liver damage and promote healing. Patients often have malnutrition, so nutritional therapy with a focus on adequate protein intake and vitamin supplementation is crucial. Corticosteroids like prednisolone may be prescribed in severe cases to reduce liver inflammation and improve survival rates. In severe cases unresponsive to medical therapy, liver transplantation may be considered, although strict criteria must be met. Diuretics may be used cautiously to manage ascites while monitoring for renal function. Prophylactic measures such as beta-blockers may be used to reduce the risk of variceal bleeding.